- Home
- GSBC vs ORGO Comparison
GSBC vs ORGO Comparison
Compare GSBC & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- ORGO
- Stock Information
- Founded
- GSBC 1923
- ORGO 1985
- Country
- GSBC United States
- ORGO United States
- Employees
- GSBC N/A
- ORGO N/A
- Industry
- GSBC Major Banks
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- GSBC Finance
- ORGO Health Care
- Exchange
- GSBC Nasdaq
- ORGO Nasdaq
- Market Cap
- GSBC 676.3M
- ORGO 620.3M
- IPO Year
- GSBC N/A
- ORGO N/A
- Fundamental
- Price
- GSBC $62.41
- ORGO $4.67
- Analyst Decision
- GSBC Hold
- ORGO Buy
- Analyst Count
- GSBC 2
- ORGO 2
- Target Price
- GSBC $60.50
- ORGO $7.50
- AVG Volume (30 Days)
- GSBC 39.8K
- ORGO 687.1K
- Earning Date
- GSBC 10-15-2025
- ORGO 08-07-2025
- Dividend Yield
- GSBC 2.55%
- ORGO N/A
- EPS Growth
- GSBC 17.24
- ORGO N/A
- EPS
- GSBC 5.86
- ORGO N/A
- Revenue
- GSBC $224,299,000.00
- ORGO $429,531,000.00
- Revenue This Year
- GSBC N/A
- ORGO $2.57
- Revenue Next Year
- GSBC N/A
- ORGO $9.80
- P/E Ratio
- GSBC $10.70
- ORGO N/A
- Revenue Growth
- GSBC 4.82
- ORGO N/A
- 52 Week Low
- GSBC $47.58
- ORGO $2.46
- 52 Week High
- GSBC $68.02
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- GSBC 64.77
- ORGO 52.75
- Support Level
- GSBC $59.37
- ORGO $4.41
- Resistance Level
- GSBC $63.00
- ORGO $4.95
- Average True Range (ATR)
- GSBC 1.31
- ORGO 0.30
- MACD
- GSBC 0.49
- ORGO -0.03
- Stochastic Oscillator
- GSBC 92.29
- ORGO 77.03
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.